Diagnostic testing after positive results on cell free DNA screening: CVS or Amnio?
Authors:
- 12 August 2021
- journal article
- review article
- Published by Wiley in Prenatal Diagnosis
- Vol. 41 (10) , 1249-1254
Abstract
Objective: The positive predictive values of cell free DNA (cfDNA) and rates of confined placental mosaicism (CPM), imprinting and other factors vary by chromosome.Methods: We sought to review the literature for each of these features for each chromosome and provide recommendations on chorionic villus sampling (CVS) versus amniocentesis after an abnormal cfDNA result.Results: For chromosomes with high rates of CPM (trisomy 13, monosomy X and rare autosomal trisomies [RATs]), an amniocentesis should be considered if the first trimester ultrasound is normal. For monosomy X on cfDNA with an unaffected fetus, maternal karyotyping should be considered after normal fetal diagnostic testing. In cfDNA cases with a trisomy involving a chromosome with imprinted genes (6, 7, 11, 14, 15 and 20), CVS should be considered, followed by amniocentesis if abnormal. If the fetus is unaffected, methylation studies should be considered given the risk of uniparental disomy. A third trimester growth ultrasound should be considered for patients with a positive cfDNA screen for a RAT and an unaffected fetus, especially in the case of trisomy 16. For patients with multiple aneuploidy results on cfDNA, a work‐up for maternal malignancy should be considered.Conclusions: Clinicians should consider rates of CPM, imprinting, ultrasound findings and maternal factors when considering whether to recommend amniocentesis or CVS after an abnormal cfDNA result.Keywords
This publication has 43 references indexed in Scilit:
- Pregnancy outcomes of prenatally diagnosed Turner syndrome: a French multicenter retrospective study including a series of 975 casesPrenatal Diagnosis, 2014
- Maternal Mosaicism Is a Significant Contributor to Discordant Sex Chromosomal Aneuploidies Associated with Noninvasive Prenatal TestingClinical Chemistry, 2014
- Committee Opinion No. 545Obstetrics & Gynecology, 2012
- Outcome of fetuses with Turner syndrome: a 10-year congenital anomaly register based studyThe Journal of Maternal-Fetal & Neonatal Medicine, 2011
- X chromosome loss and ageingCytogenetic and Genome Research, 2007
- Clinical aspects, prenatal diagnosis, and pathogenesis of trisomy 16 mosaicismJournal of Medical Genetics, 2003
- Confined placental mosaicism and genomic imprintingBest Practice & Research Clinical Obstetrics & Gynaecology, 2000
- Trisomy 16 and trisomy 16 mosaicism: A reviewAmerican Journal of Medical Genetics, 1998
- An audit of trisomy 16 in manPrenatal Diagnosis, 1995
- Efficient direct chromosome analyses and enzyme determinations from chorionic villi samples in the first trimester of pregnancyHuman Genetics, 1983